Convalescent plasma in patients receiving rituximab or ocrelizumab for multiple sclerosis or neuromyelitis Optica spectrum disorder with Covid-19: A multicenter retrospective study by Tanguy Dequidt, Quentin Richier, Céline Louapre, Florence Ader, Yanis Merad, Nicolas Lauwerier, Christine Jacomet, Michel Carles, Charlotte Biron, Vincent Gendrin, Clément Marlat, François Danion, Tristan M Lepage, Albert Sotto, Loïc Bourdellon, Alexandre Mania, Martin Martinot, Georges Le Falher, Alexis Ferre, Benoit Pilmis, Guillaume Gondran, Pierre Simeone, Matthieu Henry, Toufik Kamel, Simon Ray, Sophie Ancellin, Nicolas Mélé, Fabrice Camou, Marjolaine Destremau, Jeremy Sellenet, Noémie Zucman, Marion Le Maréchal, Khawla Mellouki, Marie-Elodie Langlois, David Luque Paz, Maud Mousset, Catherine Leclerc, Agnès Sommet, Karine Lacombe, Guillaume Martin-Blondel

Subjects: Get full text

Rituximab-IgG2 is a phagocytic enhancer in antibody-based immunotherapy of B-cell lymphoma by altering CD47 expression by Oanh T. P. Nguyen, Sandra Lara, Giovanni Ferro, Matthias Peipp, Sandra Kleinau

Subjects: “…anti-CD20 antibody…”
Get full text

Persistent SARS-CoV-2 infection resolved after B-cell recovery in a patient with follicular lymphoma treated with B-cell depletion therapy by Yuriko Sueda, Hirokazu Tokuyasu, Momoka Atsuta, Hiromitsu Sakai, Katsunori Arai, Chika Esumi, Misato Mochizuki, Tomoki Itohara, Naoki Fujisawa, Akira Yamasaki

Subjects: “…Anti-CD20 antibody…”
Get full text